It is well established that heritable risk to UM can be part of a tumor predisposition syndrome with variable manifestation and incomplete penetrance (BAP1-tumor predisposition syndrome, BAP1-TPDS), and the number of families with known oncogenic variants of the BAP1 gene has risen fast [14]. This evidence concerns the gene BAP1 and BAP1-related tumor predisposition syndrome.